{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:46:51Z","timestamp":1791121611299,"version":"4.1.0"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T00:00:00Z","timestamp":1317168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Exper Ophthalmology"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:title>A<jats:sc>bstract<\/jats:sc><\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> Caveolin\u20101 expression correlates with the permeability of endothelial barriers and angiogenesis. However, the role of caveolin\u20101 in retinal neovascularization remains unknown. We evaluated the effect of caveolin\u20101 on the blood\u2013retina barrier and retinal neovascularization in a murine model of oxygen\u2010induced retinopathy.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Starting at postnatal day 7, mice were exposed to 75\u2003\u00b1\u20035% oxygen for 5\u2003days and then returned to room air conditions to induce retinal neovascularization. Effects on blood\u2013retina barrier were evaluated by Western blot analysis of extravasated albumin in the retina. Retinal neovascularization morphology was studied by fluorescence angiography and was quantified by counts of the endothelial nuclei that protruded into the vitreous cavity. Reverse transcription\u2010polymerase chain reaction and Western blot analysis was used to examine retinal expression levels of caveolin\u20101. siRNA against caveolin\u20101 was injected intravitreally in the oxygen\u2010induced retinopathy models. Effects on caveolin\u20101 mRNA and protein, and retinal neovascularization were assessed as described above.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Caveolin\u20101 expression was found to increase during hypoxia and overexpression of caveolin\u20101 correlated with the appearance of extravascular albumin. Caveolin\u20101 siRNA reduced caveolin\u20101 mRNA and protein levels by 47.94% and 54.76%, respectively. Furthermore, caveolin\u20101 siRNA inhibition reduced retinal neovascularization by 51.3% and reduced albumin leakage by 56.32%.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Caveolin\u20101 may play an important role in induction of retinal neovascularization. SiRNA against caveolin\u20101 can inhibit experimental retinal hyperpermeability and neovascularization. Therefore, the inhibition of caveolin\u20101 may be a powerful and novel therapeutic tool for the treatment of ischaemia\u2010induced retinal diseases.<\/jats:p>","DOI":"10.1111\/j.1442-9071.2011.02656.x","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T15:27:14Z","timestamp":1311780434000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Caveolin\u20101 expression regulates blood\u2013retinal barrier permeability and retinal neovascularization in oxygen\u2010induced retinopathy"],"prefix":"10.1111","volume":"40","author":[{"given":"Xiao\u2010Feng","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao\u2010Bo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui\u2010Zhuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si\u2010Qi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,9,28]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2007.04.011"},{"key":"e_1_2_5_3_2","first-page":"361","article-title":"Ranibizumab: phase III clinical trial results","volume":"19","author":"Rosenfeld PJ","year":"2006","journal-title":"Ophthalmol Clin North Am"},{"key":"e_1_2_5_4_2","first-page":"1029","article-title":"Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis","volume":"146","author":"Dvorak HF","year":"1995","journal-title":"Am J Pathol"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64309-X"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1076\/0271-3683(200008)2121-VFT637"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/002215540405200107"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2009.01.006"},{"key":"e_1_2_5_9_2","first-page":"101","article-title":"Oxygen\u2010induced retinopathy in the mouse","volume":"35","author":"Smith LE","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-034009"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051200"},{"key":"e_1_2_5_12_2","first-page":"2110","article-title":"Normalization of retinal vascular permeability in experimental diabetes with genistein","volume":"42","author":"Nakajima M","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_13_2","first-page":"496","article-title":"Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity","volume":"43","author":"Gu X","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1276-4"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M703153200"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.107.167486"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C100613200"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1062688"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M105408200"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-007-0274-x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkh247"},{"key":"e_1_2_5_22_2","first-page":"1914","article-title":"Matsuo Nogene transfer with the intraocular tissues by different routes of administration","volume":"37","author":"Masuda I","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.10128"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01891.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21444"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110354200"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64337-4"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.3484"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000136344.27825.72"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0406092102"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.090171"}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-9071.2011.02656.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1442-9071.2011.02656.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T05:23:18Z","timestamp":1698729798000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1442-9071.2011.02656.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,28]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1111\/j.1442-9071.2011.02656.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1442-9071.2011.02656.x","archive":["Portico"],"relation":{},"ISSN":["1442-6404","1442-9071"],"issn-type":[{"value":"1442-6404","type":"print"},{"value":"1442-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,28]]},"assertion":[{"value":"2011-09-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}